Brookdale Senior Living Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report covers events occurring on June 22, 2026, specifically the Company's 2026 Annual Meeting of Stockholders. The filing details the election of directors, the departure of a director, and changes to the Board leadership structure.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Governance Events
- Director Departure: Jordan R. Asher's term as a Board member expired and he did not stand for re-election. The departure was not due to any disagreement with the Company, Board, or management.
- Leadership Transition: Denise W. Warren stepped down as Non-Executive Chairman. Mark Fioravanti was appointed as the new Non-Executive Chairman, effective immediately following the Annual Meeting. Ms. Warren will continue to serve as an independent director.
- Director Elections: Stockholders elected nine directors to one-year terms expiring at the 2027 annual meeting. All nominees received a majority of votes cast.
Voting Results
| Proposal | Votes For | Votes Against | Abstentions |
|---|---|---|---|
| Election of Directors (Proposal 1) | Varied by nominee (e.g., C. Christian Winkle: 190,890,820) | Varied by nominee (e.g., Claudia N. Drayton: 7,976,363) | Varied by nominee |
| Executive Compensation (Proposal 2) | 185,229,055 | 5,611,078 | 760,717 |
| Ratification of Auditor (Proposal 3) | 200,410,558 | 3,466,287 | 15,697 |
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, or specific risk factors. The report notes that the leadership changes are part of ordinary course succession planning.
Key Facts for Investor Verification
- Confirm the new Board composition and the specific roles of Mark Fioravanti (Non-Executive Chairman) and Denise W. Warren (Independent Director).
- Review the definitive proxy statement (Schedule 14A filed April 30, 2026) for detailed biographies of the newly elected directors and the rationale for the leadership transition.
- Verify the voting percentages for director nominees with higher "Against" vote counts (e.g., Claudia N. Drayton and Denise W. Warren) to assess shareholder sentiment.